GLUE Competitors & Alternatives
Compare Monte Rosa Therapeutics Inc with similar stocks in the same industry
Biotechnology
GLUE
Main Stock$20.71
Tradestie Score
56
Market Cap
$463.20M
Revenue Growth
-1.0%
Analyst Upside
+56.1%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLDX
Celldex Therapeutics, Inc
|
$32.98
|
$1.68B | - | 56 | Compare |
|
MNKD
Mannkind Corporation
|
$3.93
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.83
|
$1.63B | - | 67 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.78
|
$1.57B | - | 61 | Compare |
|
VCEL
Vericel Corporation
|
$40.39
|
$1.56B | 94.1 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$87.53
|
$1.55B | - | 57 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$34.16
|
$1.55B | 13.5 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$33.19
|
$1.55B | - | 67 | Compare |
|
NVAX
Novavax Inc
|
$9.00
|
$1.54B | - | 54 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$17.88
|
$1.50B | 8.1 | 65 | Compare |
More GLUE Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
225 stocks in this industry